» Articles » PMID: 15453915

Strengths and Weaknesses of EST-based Prediction of Tissue-specific Alternative Splicing

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2004 Sep 30
PMID 15453915
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alternative splicing contributes significantly to the complexity of the human transcriptome and proteome. Computational prediction of alternative splice isoforms are usually based on EST sequences that also allow to approximate the expression pattern of the related transcripts. However, the limited number of tissues represented in the EST data as well as the different cDNA construction protocols may influence the predictive capacity of ESTs to unravel tissue-specifically expressed transcripts.

Methods: We predict tissue and tumor specific splice isoforms based on the genomic mapping (SpliceNest) of the EST consensus sequences and library annotation provided in the GeneNest database. We further ascertain the potentially rare tissue specific transcripts as the ones represented only by ESTs derived from normalized libraries. A subset of the predicted tissue and tumor specific isoforms are then validated via RT-PCR experiments over a spectrum of 40 tissue types.

Results: Our strategy revealed 427 genes with at least one tissue specific transcript as well as 1120 genes showing tumor specific isoforms. While our experimental evaluation of computationally predicted tissue-specific isoforms revealed a high success rate in confirming the expression of these isoforms in the respective tissue, the strategy frequently failed to detect the expected restricted expression pattern. The analysis of putative lowly expressed transcripts using normalized cDNA libraries suggests that our ability to detect tissue-specific isoforms strongly depends on the expression level of the respective transcript as well as on the sensitivity of the experimental methods. Especially splice isoforms predicted to be disease-specific tend to represent transcripts that are expressed in a set of healthy tissues rather than novel isoforms.

Conclusions: We propose to combine the computational prediction of alternative splice isoforms with experimental validation for efficient delineation of an accurate set of tissue-specific transcripts.

Citing Articles

Expressed sequence tags for bovine muscle satellite cells, myotube formed-cells and adipocyte-like cells.

Lee E, Kamli M, Pokharel S, Malik A, Tareq K, Bhat A PLoS One. 2013; 8(11):e79780.

PMID: 24224006 PMC: 3818215. DOI: 10.1371/journal.pone.0079780.


MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data.

Shen S, Park J, Huang J, Dittmar K, Lu Z, Zhou Q Nucleic Acids Res. 2012; 40(8):e61.

PMID: 22266656 PMC: 3333886. DOI: 10.1093/nar/gkr1291.


Reproducibility and concordance of differential DNA methylation and gene expression in cancer.

Yao C, Li H, Shen X, He Z, He L, Guo Z PLoS One. 2012; 7(1):e29686.

PMID: 22235325 PMC: 3250460. DOI: 10.1371/journal.pone.0029686.


Potential molecular targeting of splice variants for cancer treatment.

Blair C, Zi X Indian J Exp Biol. 2011; 49(11):836-9.

PMID: 22126014 PMC: 3253385.


Global regulation of alternative splicing during myogenic differentiation.

Bland C, Wang E, Vu A, David M, Castle J, Johnson J Nucleic Acids Res. 2010; 38(21):7651-64.

PMID: 20634200 PMC: 2995044. DOI: 10.1093/nar/gkq614.


References
1.
Wang Z, Lo H, Yang H, Gere S, Hu Y, Buetow K . Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res. 2003; 63(3):655-7. View

2.
Megy K, Audic S, Claverie J . Heart-specific genes revealed by expressed sequence tag (EST) sampling. Genome Biol. 2003; 3(12):RESEARCH0074. PMC: 151176. DOI: 10.1186/gb-2002-3-12-research0074. View

3.
Geerlings T, Faber A, Bister M, Vos J, Raue H . Rio2p, an evolutionarily conserved, low abundant protein kinase essential for processing of 20 S Pre-rRNA in Saccharomyces cerevisiae. J Biol Chem. 2003; 278(25):22537-45. DOI: 10.1074/jbc.M300759200. View

4.
Jin X, Turcott E, Englehardt S, Mize G, Morris D . The two upstream open reading frames of oncogene mdm2 have different translational regulatory properties. J Biol Chem. 2003; 278(28):25716-21. DOI: 10.1074/jbc.M300316200. View

5.
Haas S, Hild M, Wright A, Hain T, Talibi D, Vingron M . Genome-scale design of PCR primers and long oligomers for DNA microarrays. Nucleic Acids Res. 2003; 31(19):5576-81. PMC: 206452. DOI: 10.1093/nar/gkg752. View